Aesica is a leading supplier of Active Pharmaceutical Ingredients (APIs) and Custom Synthesis solutions to the global pharmaceutical and biotechnology industries in major markets including Japan, Europe, the Middle East and North America. Our state-of-the-art technology offers the capability to manufacture development compounds in quantities for use in Phase I to III clinical trials or for high volume continuous supplies. We carry out IND/CMC requirements from the preclinical stage right through to commercial supply. cGMP custom manufacturing - Process R&D and scale-up - Full regulatory service.
